Illumina Inc (NASDAQ:ILMN)

CAPS Rating: 4 out of 5

The Company is a developer, manufacturer and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function.


Player Avatar RMITRA757 (99.22) Submitted: 2/1/2011 4:10:20 PM : Outperform Start Price: $32.62 ILMN Score: +14.63

Next generation sequencing is changing the field of Genetics. Look for the technology to move from the research market to the clinical market in the next 2-5 years. This will led to 20%+ growth of the market for many years. Illumina is the clear leader in the field, good margins, good earnings growth.

Report this Post 2 Replies
Member Avatar Suiname (36.33) Submitted: 2/23/2011 1:52:04 PM
Recs: 0

How in the world did you get a start price of 32.62 on 2/1/2011?

Member Avatar RMITRA757 (99.22) Submitted: 2/24/2011 4:57:58 PM
Recs: 0

Oh, yeah, LOL. I picked this a while back, but just now wrote my pitch. Thought maybe I'd start doing pitches now that they're giving out charms for them:)

Featured Broker Partners